# FDA Inspection 1182096 - Boehringer Ingelheim RCV GmbH & Co KG - September 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/39d7534c-cf3e-4996-a6fd-8da44ba47824
Source feed: FDA_Inspections

> FDA Inspection 1182096 for Boehringer Ingelheim RCV GmbH & Co KG on September 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1182096
- Company Name: Boehringer Ingelheim RCV GmbH & Co KG
- Inspection Date: 2022-09-16
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1258048 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/16b950bf-59de-4188-9b07-5e884ebdfe91)
- [FDA Inspection 1258048 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/5629f2fe-63c9-4137-bda3-e90b8505a984)
- [FDA Inspection 1226783 - 2023-12-05](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/58b1a87d-a90e-4ba5-b7e5-ec998156c23b)
- [FDA Inspection 1223893 - 2023-11-16](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/5b9ef9a3-8f71-4fda-8534-f0f594c7979e)
- [FDA Inspection 1210971 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-rcv-gmbh-co-kg/3cfa7c2f-3876-4a03-8a8f-2b34332d7f2c)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-rcv-gmbh-co-kg/44a0d48b-1c34-490c-87fe-ccfec769342f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d